An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results.
Lai Y., Cappellini M. D., Aydinok Y., Porter J., Karakas Z., Viprakasit V., ...Daha Fazla
American journal of hematology, cilt.97, sa.8, 2022 (SCI-Expanded, Scopus)